CN101570543A - 一种美洛西林钠溶媒结晶制备方法 - Google Patents
一种美洛西林钠溶媒结晶制备方法 Download PDFInfo
- Publication number
- CN101570543A CN101570543A CNA2009100990443A CN200910099044A CN101570543A CN 101570543 A CN101570543 A CN 101570543A CN A2009100990443 A CNA2009100990443 A CN A2009100990443A CN 200910099044 A CN200910099044 A CN 200910099044A CN 101570543 A CN101570543 A CN 101570543A
- Authority
- CN
- China
- Prior art keywords
- mezlocillin
- sodium
- solvent
- forming agent
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002904 solvent Substances 0.000 title claims abstract description 52
- 238000002360 preparation method Methods 0.000 title claims abstract description 33
- 239000013078 crystal Substances 0.000 title claims abstract description 15
- KCVTVKMPZQSSNU-UHFFFAOYSA-N 2-pyridin-4-ylethanethioyl chloride Chemical compound ClC(=S)CC1=CC=NC=C1 KCVTVKMPZQSSNU-UHFFFAOYSA-N 0.000 title claims abstract description 11
- 229960001994 mezlocillin sodium Drugs 0.000 title claims abstract description 11
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical group CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims abstract description 90
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical group CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims abstract description 60
- 239000007810 chemical reaction solvent Substances 0.000 claims abstract description 29
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims abstract description 26
- 229910052708 sodium Inorganic materials 0.000 claims abstract description 26
- 239000011734 sodium Substances 0.000 claims abstract description 26
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 23
- 239000000706 filtrate Substances 0.000 claims abstract description 23
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims abstract description 22
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims abstract description 21
- 150000003839 salts Chemical class 0.000 claims abstract description 21
- 238000000034 method Methods 0.000 claims abstract description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 18
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims abstract description 16
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 claims abstract description 12
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims abstract description 11
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims abstract description 11
- 238000006243 chemical reaction Methods 0.000 claims abstract description 10
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims abstract description 8
- 238000001035 drying Methods 0.000 claims abstract description 7
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 claims abstract description 5
- WBJINCZRORDGAQ-UHFFFAOYSA-N formic acid ethyl ester Natural products CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 claims abstract description 4
- 238000001914 filtration Methods 0.000 claims abstract 3
- 229960000198 mezlocillin Drugs 0.000 claims description 34
- YPBATNHYBCGSSN-VWPFQQQWSA-N mezlocillin Chemical compound N([C@@H](C(=O)N[C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C=1C=CC=CC=1)C(=O)N1CCN(S(C)(=O)=O)C1=O YPBATNHYBCGSSN-VWPFQQQWSA-N 0.000 claims description 33
- 238000011084 recovery Methods 0.000 claims description 22
- OEOIWYCWCDBOPA-UHFFFAOYSA-N 6-methyl-heptanoic acid Chemical compound CC(C)CCCCC(O)=O OEOIWYCWCDBOPA-UHFFFAOYSA-N 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 8
- -1 filter Substances 0.000 claims description 7
- 239000012065 filter cake Substances 0.000 claims description 7
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 claims description 6
- 229940043232 butyl acetate Drugs 0.000 claims description 6
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 claims description 6
- 239000000126 substance Substances 0.000 claims description 6
- OBETXYAYXDNJHR-SSDOTTSWSA-M (2r)-2-ethylhexanoate Chemical compound CCCC[C@@H](CC)C([O-])=O OBETXYAYXDNJHR-SSDOTTSWSA-M 0.000 claims description 4
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 claims description 4
- HBBHCQMGWUQAGL-UHFFFAOYSA-N methyl 3-oxobutanoate;sodium Chemical compound [Na].COC(=O)CC(C)=O HBBHCQMGWUQAGL-UHFFFAOYSA-N 0.000 claims description 4
- 239000000047 product Substances 0.000 abstract description 15
- 238000004519 manufacturing process Methods 0.000 abstract description 11
- 239000012535 impurity Substances 0.000 abstract description 3
- VWHSJZHUWWEFAC-UHFFFAOYSA-N 2-(5-amino-3-phenylpyrazol-1-yl)ethanol Chemical compound OCCN1C(N)=CC(C=2C=CC=CC=2)=N1 VWHSJZHUWWEFAC-UHFFFAOYSA-N 0.000 abstract description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 abstract 1
- GTBXAGPZKPTPEJ-UHFFFAOYSA-N CC[Na].CCCCCC(O)=O Chemical compound CC[Na].CCCCCC(O)=O GTBXAGPZKPTPEJ-UHFFFAOYSA-N 0.000 abstract 1
- XYIBRDXRRQCHLP-UHFFFAOYSA-N ethyl acetoacetate Chemical compound CCOC(=O)CC(C)=O XYIBRDXRRQCHLP-UHFFFAOYSA-N 0.000 abstract 1
- GTGQRSIMEUWHPA-ZBJAFUORSA-M mezlocillin sodium Chemical compound [Na+].N([C@@H](C(=O)N[C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C=1C=CC=CC=1)C(=O)N1CCN(S(C)(=O)=O)C1=O GTGQRSIMEUWHPA-ZBJAFUORSA-M 0.000 description 38
- 239000007787 solid Substances 0.000 description 23
- 238000004128 high performance liquid chromatography Methods 0.000 description 21
- 239000000243 solution Substances 0.000 description 12
- 238000002425 crystallisation Methods 0.000 description 11
- 238000004108 freeze drying Methods 0.000 description 7
- 230000008025 crystallization Effects 0.000 description 6
- 229960004756 ethanol Drugs 0.000 description 4
- 238000007605 air drying Methods 0.000 description 3
- 238000002386 leaching Methods 0.000 description 3
- 239000012046 mixed solvent Substances 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 125000003368 amide group Chemical group 0.000 description 2
- BQFCCCIRTOLPEF-UHFFFAOYSA-N chembl1976978 Chemical compound CC1=CC=CC=C1N=NC1=C(O)C=CC2=CC=CC=C12 BQFCCCIRTOLPEF-UHFFFAOYSA-N 0.000 description 2
- SWXVUIWOUIDPGS-UHFFFAOYSA-N diacetone alcohol Natural products CC(=O)CC(C)(C)O SWXVUIWOUIDPGS-UHFFFAOYSA-N 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000005265 energy consumption Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- FCPVYOBCFFNJFS-LQDWTQKMSA-M benzylpenicillin sodium Chemical compound [Na+].N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)CC1=CC=CC=C1 FCPVYOBCFFNJFS-LQDWTQKMSA-M 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000002389 essential drug Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000010297 mechanical methods and process Methods 0.000 description 1
- 230000005226 mechanical processes and functions Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 150000002960 penicillins Chemical class 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000000859 sublimation Methods 0.000 description 1
- 230000008022 sublimation Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Cephalosporin Compounds (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100990443A CN101570543B (zh) | 2009-06-04 | 2009-06-04 | 一种美洛西林钠溶媒结晶制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100990443A CN101570543B (zh) | 2009-06-04 | 2009-06-04 | 一种美洛西林钠溶媒结晶制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101570543A true CN101570543A (zh) | 2009-11-04 |
CN101570543B CN101570543B (zh) | 2011-05-25 |
Family
ID=41230039
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009100990443A Expired - Fee Related CN101570543B (zh) | 2009-06-04 | 2009-06-04 | 一种美洛西林钠溶媒结晶制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101570543B (zh) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102367258A (zh) * | 2010-10-26 | 2012-03-07 | 海南美好西林生物制药有限公司 | 一种美洛西林钠的制备方法 |
CN103275100A (zh) * | 2013-06-09 | 2013-09-04 | 四川省惠达药业有限公司 | 美洛西林钠化合物、其制备方法及其药物组合物 |
CN104910182A (zh) * | 2015-05-28 | 2015-09-16 | 浙江长典医药有限公司 | 一种小儿用美洛西林钠化合物实体及其制剂 |
CN108610352A (zh) * | 2018-06-12 | 2018-10-02 | 山东鲁抗医药股份有限公司 | 一种溶媒结晶制备美洛西林钠的方法 |
CN109575047A (zh) * | 2018-12-21 | 2019-04-05 | 四川制药制剂有限公司 | 注射用美洛西林钠的制备方法 |
CN111471057A (zh) * | 2020-04-28 | 2020-07-31 | 江苏海宏制药有限公司 | 一种溶媒结晶制备美洛西林钠的工艺 |
CN113121569A (zh) * | 2021-04-20 | 2021-07-16 | 海南通用三洋药业有限公司 | 一种美洛西林钠的制备方法 |
CN115043747A (zh) * | 2022-08-15 | 2022-09-13 | 康瑞鑫(天津)药物研究院有限公司 | 卡洛酸三钠的析晶方法及制备的卡洛酸三钠晶体 |
-
2009
- 2009-06-04 CN CN2009100990443A patent/CN101570543B/zh not_active Expired - Fee Related
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102367258A (zh) * | 2010-10-26 | 2012-03-07 | 海南美好西林生物制药有限公司 | 一种美洛西林钠的制备方法 |
CN103275100A (zh) * | 2013-06-09 | 2013-09-04 | 四川省惠达药业有限公司 | 美洛西林钠化合物、其制备方法及其药物组合物 |
CN103275100B (zh) * | 2013-06-09 | 2015-09-09 | 四川省惠达药业有限公司 | 美洛西林钠化合物、其制备方法及其药物组合物 |
CN104910182A (zh) * | 2015-05-28 | 2015-09-16 | 浙江长典医药有限公司 | 一种小儿用美洛西林钠化合物实体及其制剂 |
CN108610352A (zh) * | 2018-06-12 | 2018-10-02 | 山东鲁抗医药股份有限公司 | 一种溶媒结晶制备美洛西林钠的方法 |
CN109575047A (zh) * | 2018-12-21 | 2019-04-05 | 四川制药制剂有限公司 | 注射用美洛西林钠的制备方法 |
CN109575047B (zh) * | 2018-12-21 | 2021-04-13 | 四川制药制剂有限公司 | 注射用美洛西林钠的制备方法 |
CN111471057A (zh) * | 2020-04-28 | 2020-07-31 | 江苏海宏制药有限公司 | 一种溶媒结晶制备美洛西林钠的工艺 |
CN113121569A (zh) * | 2021-04-20 | 2021-07-16 | 海南通用三洋药业有限公司 | 一种美洛西林钠的制备方法 |
CN115043747A (zh) * | 2022-08-15 | 2022-09-13 | 康瑞鑫(天津)药物研究院有限公司 | 卡洛酸三钠的析晶方法及制备的卡洛酸三钠晶体 |
Also Published As
Publication number | Publication date |
---|---|
CN101570543B (zh) | 2011-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101570543B (zh) | 一种美洛西林钠溶媒结晶制备方法 | |
CN101863784B (zh) | 一种甜菜碱、甜菜碱盐酸盐的制备提取方法 | |
CN101619069A (zh) | 一种头孢替安酯盐酸盐的制备方法 | |
CN102702232A (zh) | 一种精制头孢孟多酯钠的方法 | |
CN103204823A (zh) | 一种1,2-苯并异噻唑-3-酮的提纯方法 | |
CN103159816A (zh) | 一种从植物甾醇发酵液中提取4-雄烯二酮的方法 | |
CN103012437B (zh) | 抗菌药物头孢西丁酸的制备方法 | |
CN101585845B (zh) | 美洛西林的制备方法 | |
CN117447427A (zh) | 一种呋塞米的制备方法 | |
CN102174007A (zh) | [2-(2-氰基-吡咯烷-1-基)-2-氧代-乙基]-氨基甲酸叔丁基酯的工业化制备方法 | |
CN102603597B (zh) | (s)-奥拉西坦的制备方法 | |
CN111471057A (zh) | 一种溶媒结晶制备美洛西林钠的工艺 | |
CN110511156A (zh) | 一种赖氨匹林的制备方法 | |
CN102964396B (zh) | 一种三氯蔗糖-6-乙酯重结晶的方法 | |
CN115557904A (zh) | 一种适合规模生产5,7-双(三氟甲基)喹唑啉-2,4-二酮的合成方法 | |
CN101811979B (zh) | 注射级土霉素生产工艺 | |
CN100469750C (zh) | 从葡萄糖酸钙结晶后母液中提取葡萄糖酸钙的方法 | |
CN103275153A (zh) | 一种非达霉素晶体的制备方法 | |
CN102086213B (zh) | 一种氯唑西林钠的结晶制备方法 | |
CN103664941B (zh) | 一种长春西汀类似物的制备方法 | |
CN101823986A (zh) | 一种肼基甲酸叔丁酯的制备方法 | |
CN102731340A (zh) | 去甲基金霉素盐酸盐制备方法 | |
CN105315300A (zh) | 一种头孢西丁钠、其制备方法及用途 | |
CN105254650A (zh) | 抗菌药物头孢西丁酸的合成方法 | |
CN109134385A (zh) | 一种尿嘧啶类化合物的纯化方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Wang Bo Inventor after: Li Yongshu Inventor after: Tan Chengxia Inventor before: Li Yongshu Inventor before: Tan Chengxia |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: LI YONGSHU TAN CHENGXIA TO: WANG BO LI YONGSHU TAN CHENGXIA |
|
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20091104 Assignee: JIANGSU HAI-HONG PHARMACEUTICAL Co.,Ltd. Assignor: Zhejiang University of Technology Contract record no.: 2014320000461 Denomination of invention: Preparation method of mezlocillin sodium solvent crystal Granted publication date: 20110525 License type: Exclusive License Record date: 20140529 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110525 |
|
CF01 | Termination of patent right due to non-payment of annual fee |